Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Assets Average (2016 - 2025)

Avanos Medical's Assets Average history spans 11 years, with the latest figure at $1.7 billion for Q3 2024.

  • For Q3 2024, Assets Average fell 2.29% year-over-year to $1.7 billion; the TTM value through Sep 2024 reached $1.7 billion, down 2.29%, while the annual FY2023 figure was $1.7 billion, 2.62% up from the prior year.
  • Assets Average for Q3 2024 was $1.7 billion at Avanos Medical, roughly flat from $1.7 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.8 billion in Q1 2020 and bottomed at $1.6 billion in Q4 2021.
  • The 5-year median for Assets Average is $1.7 billion (2023), against an average of $1.7 billion.
  • The largest annual shift saw Assets Average fell 7.79% in 2021 before it rose 11.26% in 2022.
  • A 5-year view of Assets Average shows it stood at $1.7 billion in 2020, then dropped by 7.79% to $1.6 billion in 2021, then grew by 11.26% to $1.8 billion in 2022, then decreased by 4.07% to $1.7 billion in 2023, then dropped by 3.02% to $1.7 billion in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Assets Average are $1.7 billion (Q3 2024), $1.7 billion (Q2 2024), and $1.7 billion (Q1 2024).